Physician profile
Gary Willers
NPI 1255625422
$2,487.24
in general payments reported to CMS, 2019-2025
38 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $333 · 2021: $480 · 2022: $425 · 2023: $378 · 2024: $281 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.28 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $195.54 | 2019-2021 | |
| Abbvie INC. | $180.43 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $161.68 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Novartis Pharmaceuticals Corporation | $157.62 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.12 | 2019-2024 | Ofev, Jardiance |
| Astellas Pharma US INC | $146.82 | 2019-2023 | Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $146.22 | 2019-2025 | Rexulti |
| Lilly USA, LLC | $129.21 | 2019-2024 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $122.93 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $122.12 | 2019 | |
| Novo Nordisk INC | $104.32 | 2019-2022 | |
| Stryker Corporation | $72.80 | 2025 | Limflow System |
| Intuitive Surgical, INC. | $62.86 | 2023 | Da Vinci Surgical System |
| Pfizer INC. | $62.58 | 2019-2020 | |
| Amgen INC. | $57.60 | 2020-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Willers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.